HOPE 1 SPV

Hope Biosciences is a clinical-stage biotechnology company specializing in the development and manufacturing of personalized mesenchymal stem cell (MSC) therapies. Based in Sugar Land, Texas, the company utilizes a proprietary, patented cell culture process to produce high-volume, high-purity adipose-derived MSCs (HB-adMSCs) from a patient's own tissue. These cells are currently being evaluated in over 30 FDA-cleared clinical trials targeting a wide range of indications, including neurodegenerative diseases, autoimmune disorders, and chronic inflammatory conditions. Hope Biosciences operates a unique business model that integrates a commercial cell bank with a non-profit research foundation to accelerate the delivery of regenerative treatments. Their technology platform addresses the critical challenge of scalability in cell therapy by consistently producing billions of viable cells from a single tissue sample.